Imaging CRF X NOP Interactions in CUD
Imaging Corticotrophin-releasing Factor (CRF) X Nociceptive Opioid Peptide (NOP) Interactions in Cocaine Use Disorders (Aim 1)
Rajesh Narendran
80 participants
Dec 31, 2020
INTERVENTIONAL
Conditions
Summary
This study uses \[11C\]NOP-1A positron emission tomography (PET) and a hydrocortisone challenge to image the interaction between nociceptive opioid peptide (NOP) receptors and cortisol/corticotrophin releasing factor (CRF) in subjects with cocaine use disorders (CUD) and matched healthy controls (HC). It will also examine whether alterations in CRF x NOP interactions predict relapse in subjects with CUD.
Eligibility
Inclusion Criteria14
- Cocaine use disorders (CUD)
- Males or females between 18 and 55 years old
- Fulfil DSM-5 criteria for cocaine use disorder
- No other current DSM-5 psychiatric or addictive disorders (such as major depressive disorder, bipolar disorders, psychotic disorders, etc.,)
- No current abuse (six months) of opiates, sedative-hypnotics, amphetamines, MDMA, etc., as well as moderate to severe alcohol or cannabis use (twice a week). Nicotine use will be quantified and controlled between groups using the Fagerstrom Test for Nicotine Dependence (Heatherton et al., 1991);
- Not currently on prescription medical or psychotropic medications
- No current or past severe medical, endocrine or neurological illnesses including glaucoma, seizure disorders, hypertension, hypercholesterolemia as assessed by a complete medical history and physical
- Not currently pregnant or breastfeeding
- No history of significant radioactivity exposure in past year from another research study or occupation that exceeds RDRC guidelines
- No metallic objects in the body that are contraindicated for MRI
- Healthy Controls (HC)
- Males or females between 18 and 55 years old
- No present or past DSM-5 disorders (other than nicotine dependence)
- Criteria 5 to 9 as listed previously.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Radiotracer
Intravenous, 1mg/Kg
Radiotracer
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05008146